Trials / Completed
CompletedNCT02411500
A Pharmacokinetic, Safety and Tolerability Study in Healthy Adult Males
A Randomized, Open Label, Four Period, Cross-Over Study to Evaluate the Pharmacokinetics of Single Doses of Various TRV734 Formulations in Healthy Male Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 18 (actual)
- Sponsor
- Trevena Inc. · Industry
- Sex
- Male
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The primary objective of this study is to evaluate the pharmacokinetics of various TRV734 formulations in healthy male subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | TRV734 | Subjects will be randomized to receive the oral TRV734 treatments on Days 1, 3, 5 and 7 in an open-label, 4-period, cross-over fashion. Days 2, 4, 6 and 8 are designated as washout days. |
Timeline
- Start date
- 2015-02-01
- Primary completion
- 2015-03-01
- Completion
- 2015-03-01
- First posted
- 2015-04-08
- Last updated
- 2015-11-18
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02411500. Inclusion in this directory is not an endorsement.